• Email Preferences
    • Logout
    loading
  • +44 (0)20 8762 8008
  • Change Language
    [Close]
      • Language English
      • Language Japanese
      LanguageEnglish
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • Overview
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs

Quick Links

  • Home
  • About Us
  • Careers
  • CSR
  • Foundation
International SOS Logo
View Map
  • +44 (0)20 8762 8008 Call for Assistance
    • Language English
    • Language Japanese
    LanguageEnglish
  • Search
    • Email Preferences
    • Logout
    loading
    Member
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs
  • About Us
  • Careers
  • CSR
  • Foundation
  • Pandemic Preparedness
  • 2019-nCoV
Print

COVID-19

 


Public Access

Interactive COVID-19 Data by Location

COVID-19 Case Count Trackers

Education and Communication

COVID-19 FAQs and External Resources

COVID-19 Videos

 

 

 

Member Access

 

Travel Restrictions, Flight Operations and Screening

Digital Passports

COVID-19 Digital Passports


Scientific Update

COVID-19 FAQs

COVID-19 Vaccine

COVID19 Vaccine FAQs

COVID-19 Vaccine FAQs

Variant

COVID-19 Variants

COVID-19 Testing

COVID-19 Treatment

Use of Face Masks by the General Public

COVID-19 Travel Advice


 

COVID-19 Disease and Prevention Article


Sign up for Emails and Alerts

 

Premium Services Member Access

 

 

 

COVID-19 Manager Advice


 

COVID-19 Case Definitions used by different authorities

Impact Tool

Pandemic Local Impact Tool

COVID-19 Communication Material


 

COVID modelling with R0 equations

COVID-19 Modelling

COVID-19 Useful Links


 

HOT TOPICS (PREMIUM ACCESS)

  1. …
  2. 104
  3. 105
  4. 106
  5. 107
  6. 108
  7. …
  • What defines an efficacious COVID-19 vaccine?

    28 October, 2020

    An article in the Lancet looks at what defines an efficacious vaccine...

    COVID-19

  • Lancet article reviews UK vaccine planning

    United Kingdom // 28 October, 2020

    The UK has set up its Vaccine Taskforce...

    COVID-19

  • Studies: Post COVID-19 features

    28 October, 2020

    Studies on post COVID-19 features

    COVID-19

  • Russia applies for WHO emergency use for vaccine

    Russia // 28 October, 2020

    An application for its COVID-19 vaccine, Sputnik V...

    COVID-19

  • Use of Personal Protective Measures and Risk of COVID-19 Infection: study

    28 October, 2020

    Effectiveness of personal protective measures against COVID-19 infection...

    COVID-19

  • COVID-19 and Aircraft

    28 October, 2020

    Large outbreak of COVID-19 linked to air travel...

    COVID-19

  • Studies: Transmissibility of COVID-19

    28 October, 2020

    "Infectiousness profile" of SARS-CoV-2...

    COVID-19, General Articles

  • WHO weekly COVID-19 update: Exponential increase in cases in Europe

    28 October, 2020

    "In the past week the highest number of new COVID-19 cases have been reported globally, amounting to over 2 million new cases in the past 7 days "....

    COVID-19

  • Pre-Print Showing Waning Antibodies and Responses from Two Scientists

    27 October, 2020

    A look at a study on waning SARS-CoV2 antibodies and responses from two scientists...

    COVID-19

  • Decline in antibody against COVID-19 over time: study

    27 October, 2020

    Antibody response to SARS-CoV-2 waned over time in a study across England...

    COVID-19

  • Less than 4% of people in Wuhan have the antibodies against SARS-CoV-2: study

    China // 27 October, 2020

    Wuhan far from achieving herd immunity...

    COVID-19

  • Study links air pollution with increased COVID-19 mortality

    27 October, 2020

    Increased levels of air pollution found to increase risk of COVID-19 mortality…

    COVID-19, General Articles, Air Pollution

  • German health minister expects a COVID-19 vaccine will be available early 2021

    Germany // 27 October, 2020

    Vaccine against COVID-19 for the German population ...

    COVID-19

  • SARS-CoV-2 and skin manifestation

    27 October, 2020

    Researchers assessed the diagnostic value of new skin rashes in...

    COVID-19

  • Study finds loss of sense of smell highly specific to COVID-19

    27 October, 2020

    A study conducted in London, UK has found that loss of smell (anosmia) is a highly specific symptom of COVID-19...

    COVID-19

  • Effect of doxycycline on COVID-19 clinical outcomes

    27 October, 2020

    Doxycycline has been found to improve clinical outcomes...

    COVID-19

  • Study: Lessons learnt from New Zealand's pandemic control efforts

    27 October, 2020

    Effective implementation of NPIs helped New Zealand gain control over COVID-19

    COVID-19

  • Eli Lilly Pauses Monoclonal Antibody Trial

    United States // 26 October, 2020

    One trial of LY-CoV555 antibody treatment found no benefit and has been stopped...

    COVID-19

  • Key aspects following the introduction of new COVID-19 vaccines in the EU and the UK, by ECDC

    26 October, 2020

    Approaches to ensure vaccines remain available if supply is limited...

    COVID-19

  • Vitamin C, a potential therapeutic candidate for COVID-19

    26 October, 2020

    Vitamin C's antioxidant and anti-inflammatory effects...

    COVID-19

  1. …
  2. 104
  3. 105
  4. 106
  5. 107
  6. 108
  7. …
  • Pandemic Home
  • Privacy
  • Contact Us
  • Feedback
  • Terms and Conditions
Footer Image


GeoNames logo

Additional data provided by

© 2024 International SOS